| Dual SMAD signaling inhibition enables long-term expansion of diverse epithelial basal cells H Mou, V Vinarsky, PR Tata, K Brazauskas, SH Choi, AK Crooke, B Zhang, ... Cell stem cell 19 (2), 217-231, 2016 | 402 | 2016 |
| CFTR modulator theratyping: Current status, gaps and future directions JP Clancy, CU Cotton, SH Donaldson, GM Solomon, DR VanDevanter, ... Journal of Cystic Fibrosis 18 (1), 22-34, 2019 | 279 | 2019 |
| Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: a clinical trial DP Nichols, AC Paynter, SL Heltshe, SH Donaldson, CA Frederick, ... American journal of respiratory and critical care medicine 205 (5), 529-539, 2022 | 271 | 2022 |
| Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice LA Hancock, CE Hennessy, GM Solomon, E Dobrinskikh, A Estrella, ... Nature communications 9 (1), 5363, 2018 | 214 | 2018 |
| Potential role of high-mobility group box 1 in cystic fibrosis airway disease SM Rowe, PL Jackson, G Liu, M Hardison, A Livraghi, GM Solomon, ... American journal of respiratory and critical care medicine 178 (8), 822-831, 2008 | 130 | 2008 |
| Airway progenitor clone formation is enhanced by Y-27632–dependent changes in the transcriptome SD Reynolds, C Rios, A Wesolowska-Andersen, Y Zhuang, M Pinter, ... American journal of respiratory cell and molecular biology 55 (3), 323-336, 2016 | 115 | 2016 |
| Breakthrough therapies: cystic fibrosis (CF) potentiators and correctors GM Solomon, SG Marshall, BW Ramsey, SM Rowe Pediatric pulmonology 50 (S40), S3-S13, 2015 | 96 | 2015 |
| Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations NE West, VV Beckett, R Jain, DB Sanders, JA Nick, SL Heltshe, ... Journal of Cystic Fibrosis 16 (5), 600-606, 2017 | 94 | 2017 |
| The economic burden of bronchiectasis–known and unknown: a systematic review PC Goeminne, F Hernandez, R Diel, A Filonenko, R Hughes, F Juelich, ... BMC pulmonary medicine 19, 1-11, 2019 | 89 | 2019 |
| Standardized Treatment of Pulmonary Exacerbations (STOP) study: observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations DB Sanders, GM Solomon, VV Beckett, NE West, CL Daines, SL Heltshe, ... Journal of Cystic Fibrosis 16 (5), 592-599, 2017 | 86 | 2017 |
| Systematic computational identification of variants that activate exonic and intronic cryptic splice sites M Lee, P Roos, N Sharma, M Atalar, TA Evans, MJ Pellicore, E Davis, ... The American Journal of Human Genetics 100 (5), 751-765, 2017 | 86 | 2017 |
| PROMISE: working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy DP Nichols, SH Donaldson, CA Frederick, SD Freedman, D Gelfond, ... Journal of Cystic Fibrosis 20 (2), 205-212, 2021 | 73 | 2021 |
| In vivo imaging of airway cilia and mucus clearance with micro-optical coherence tomography KK Chu, C Unglert, TN Ford, D Cui, RW Carruth, K Singh, L Liu, SE Birket, ... Biomedical optics express 7 (7), 2494-2505, 2016 | 72 | 2016 |
| Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI SJ Schwarzenberg, PT Vu, M Skalland, LR Hoffman, C Pope, D Gelfond, ... Journal of Cystic Fibrosis 22 (2), 282-289, 2023 | 71 | 2023 |
| Mycobacterium abscessus Induces a Limited Pattern of Neutrophil Activation That Promotes Pathogen Survival KC Malcolm, EM Nichols, SM Caceres, JE Kret, SL Martiniano, SD Sagel, ... PloS one 8 (2), e57402, 2013 | 71 | 2013 |
| MicroRNA-145 antagonism reverses TGF-β inhibition of F508del CFTR correction in airway epithelia F Lutful Kabir, N Ambalavanan, G Liu, P Li, GM Solomon, CV Lal, ... American journal of respiratory and critical care medicine 197 (5), 632-643, 2018 | 69 | 2018 |
| Combination therapy with cystic fibrosis transmembrane conductance regulator modulators augment the airway functional microanatomy SE Birket, KK Chu, GH Houser, L Liu, CM Fernandez, GM Solomon, V Lin, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 310 …, 2016 | 69 | 2016 |
| Acquired cystic fibrosis transmembrane conductance regulator dysfunction in chronic bronchitis and other diseases of mucus clearance SV Raju, GM Solomon, MT Dransfield, SM Rowe Clinics in chest medicine 37 (1), 147-158, 2016 | 69 | 2016 |
| Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR SH Donaldson, GM Solomon, PL Zeitlin, PA Flume, A Casey, K McCoy, ... Journal of Cystic Fibrosis 16 (3), 371-379, 2017 | 67 | 2017 |
| The therapeutic potential of CFTR modulators for COPD and other airway diseases GM Solomon, L Fu, SM Rowe, JF Collawn Current opinion in pharmacology 34, 132-139, 2017 | 64 | 2017 |
